Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals CorpfiledCriticalBayer Pharmaceuticals Corp
Priority to DO2005000109ApriorityCriticalpatent/DOP2005000109A/en
Publication of DOP2005000109ApublicationCriticalpatent/DOP2005000109A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion se refiere a nuevos compuestos con estructura de pirrolotriazina, a composiciones farmaceuticas que contienen tales compuestos y al use de esos compuestos y composiciones para la prevencion y/o tratamiento de trastornos hiper-proliferativos y enfermedades asociadas con la angiogenesis.The present invention relates to new compounds with a pyrrolotriazine structure, to pharmaceutical compositions containing such compounds and to the use of those compounds and compositions for the prevention and / or treatment of hyper-proliferative disorders and diseases associated with angiogenesis.
DO2005000109A2005-05-022005-05-02
USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENISIS
DOP2005000109A
(en)
Substituted pyridylamide compounds, preparation of such and pharmaceutical compositions containing them, and use as modulators of the histamine H3 receptor